The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease
Glucocorticosteroids are the mainstay of treatment of active Crohn's disease and ulcerative colitis. These drugs however carry important cosmetic short-term side effects and when used long-term they induce severe irreversible complications. Topically acting glucocorticosteroids, especially bude...
Saved in:
Main Author: | P. Rutgeerts |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1998-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09629359891036 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the Clinical Efficacy of Prednisolone in the Treatment of Inflammatory Bowel Diseases with Different Dosage Methods
by: O. P. Alekseeva, et al.
Published: (2023-05-01) -
Topical steroids as alternative to systemic hormonal treatment for inflammatory bowel diseases in pediatric practice
by: E. N. Fedulova, et al.
Published: (2011-05-01) -
Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01) -
Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01) -
The current standard of care of inflammatory bowel disease
by: J Wright
Published: (2024-03-01)